AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

NXT Nutritionals Holdings, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
7.39K
AVG Volume
24.76K
Trailing/Forward PE
0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
0250K500K750K1M09 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
11 Q4237.99K
11 Q3177.68K
11 Q2114.67K
11 Q1128.97K
10 Q4187.52K
10 Q3379.1K
10 Q2612.72K
10 Q1811.55K
09 Q4905.73K
09 Q3687.64K
Net Income (USD) · TTM
-30M-20M-10M009 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
11 Q4-1.34M
11 Q3-7.07M
11 Q2-15.68M
11 Q1-14.35M
10 Q4-17.4M
10 Q3-14.39M
10 Q2-21.45M
10 Q1-25.59M
09 Q4-23.95M
09 Q3-19.54M
Operating Income (USD) · TTM
-8M-6M-4M-2M009 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
11 Q4-4.45M
11 Q3-3.98M
11 Q2-4.05M
11 Q1-4.12M
10 Q4-3.84M
10 Q3-6.38M
10 Q2-6.31M
10 Q1-6.31M
09 Q4-6.97M
09 Q3-2.77M
EBITDA (USD) · TTM
-5M05M10M15M09 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
11 Q4-4.45M
11 Q31.69M
11 Q24.65M
11 Q14.59M
10 Q45.61M
10 Q3-2.6M
10 Q29.39M
10 Q110.4M
09 Q48.95M
09 Q313.15M
Cash Flows (USD) · TTM
-4M-3M-2M-1M009 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
11 Q4-2.15M
11 Q3-2.46M
11 Q2-3.26M
11 Q1-3.3M
10 Q4-3.04M
10 Q3-2.45M
10 Q2-2.09M
10 Q1-2.23M
09 Q4-2.12M
09 Q3-1.9M
EPS (USD) · TTM
-0.6-0.4-0.2-00.209 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
11 Q40.01
11 Q30.01
11 Q2-0.17
11 Q1-0.16
10 Q4-0.24
10 Q3-0.24
10 Q2-0.49
10 Q1-0.55
09 Q4-0.52
09 Q3-0.52
Expenses (USD) · TTM
02M4M6M8M09 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
11 Q43.54M
11 Q33.61M
11 Q23.73M
11 Q13.81M
10 Q43.59M
10 Q36.32M
10 Q26.24M
10 Q16.28M
09 Q46.91M
09 Q32.7M
Shares Outstanding · TTM
-6M-4M-2M009 Q309 Q410 Q110 Q210 Q310 Q411 Q111 Q211 Q311 Q4
NXTH Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
11 Q4-1.48M
11 Q3-1.14M
11 Q2-1.18M
11 Q1-1.06M
10 Q4-1.08M
10 Q3-4.27M
10 Q2-4.04M
10 Q1-4.01M
09 Q4-4.46M
09 Q3-609.84K
PE Ratio
20003000400050006000med 4589.75Jan 09Feb 09Mar 09Apr 09May 09May 09Jun 09
NXTH PE Ratio by quarter
PeriodPE Ratio
Jun 094028.1
Jun 092871.52
Jun 094586.45
Jun 094187.63
May 094028.1
May 093788.81
May 094267.39
May 094028.1
May 094626.33
Apr 094905.51
Apr 094347.16
Apr 094387.04
Apr 094586.45
Mar 095684.47
Mar 095684.47
Mar 095684.47
Mar 095775.42
Feb 095411.61
Feb 094774.95
Feb 094820.43
Feb 094593.05
Jan 094593.05
Jan 094593.05
Jan 094593.05
Jan 092296.52
Jan 092296.52
Free Cash Flow Yield
-300%-200%-100%0%med -24.97%Dec 09Jul 10Oct 10Feb 11Aug 11Dec 11Mar 12
NXTH Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Mar 12-203.04%
Mar 12-200.4%
Mar 12-188.13%
Mar 12-200.4%
Feb 12-192.05%
Feb 12-192.05%
Feb 12-177.27%
Feb 12-192.05%
Jan 12-230.45%
Jan 12-188.13%
Jan 12-184.36%
Jan 12-196.97%
Dec 11-297.36%
Dec 11-295.17%
Dec 11-222.97%
Dec 11-247.95%
Dec 11-167.53%
Nov 11-156.93%
Nov 11-154.97%
Nov 11-134.75%
Nov 11-126.5%
Oct 11-221.38%
Oct 11-199.96%
Oct 11-225.41%
Oct 11-258.28%
Sep 11-229.58%
Sep 11-250.25%
Sep 11-260.26%
Sep 11-206.56%
Sep 11-144.59%
Aug 11-135.55%
Aug 11-125.13%
Aug 11-118.3%
Aug 11-122.77%
Jul 11-118.3%
Jul 11-122.77%
Jul 11-114.15%
Jul 11-98.59%
Jul 11-104.95%
Mar 11-31%
Mar 11-29.27%
Mar 11-35.15%
Mar 11-25.09%
Feb 11-23.42%
Feb 11-22.42%
Feb 11-21.08%
Feb 11-20.75%
Jan 11-21.51%
Jan 11-21.08%
Jan 11-21.08%
Jan 11-21.08%
Dec 10-21.96%
Dec 10-18.18%
Dec 10-17.68%
Dec 10-14.66%
Dec 10-18.25%
Nov 10-20.93%
Nov 10-20.66%
Nov 10-20.66%
Nov 10-22.72%
Oct 10-20.75%
Oct 10-21.14%
Oct 10-24.3%
Oct 10-21.14%
Oct 10-23.67%
Sep 10-27.47%
Sep 10-24.62%
Sep 10-21.75%
Sep 10-23.73%
Aug 10-21.84%
Aug 10-24.28%
Aug 10-26.77%
Aug 10-28.21%
Jul 10-30.7%
Jul 10-27.47%
Jul 10-26.1%
Jul 10-27.47%
Jul 10-24.86%
Mar 10-8.51%
Mar 10-5.72%
Mar 10-7.52%
Mar 10-6.21%
Feb 10-9.35%
Feb 10-4.18%
Feb 10-3.84%
Feb 10-1.92%
Jan 10-3.37%
Jan 10-3.46%
Jan 10-3.46%
Jan 10-2.97%
Dec 09-3.71%
Dec 09-2.33%
Dec 09-2.02%
Dec 09-1.93%
Dec 09-1.58%
Nov 09-2.08%
Nov 09-2.43%
Nov 09-2.74%
Nov 09-1.83%
Oct 09-1.91%
Price to Sales
050100150200med 18.4Dec 09Jul 10Oct 10Feb 11Aug 11Dec 11Mar 12
NXTH Price to Sales by quarter
PeriodPrice to Sales
Mar 126.82
Mar 126.91
Mar 127.37
Mar 126.91
Feb 127.22
Feb 127.22
Feb 127.82
Feb 127.22
Jan 126.01
Jan 127.37
Jan 127.52
Jan 127.03
Dec 114.66
Dec 119.64
Dec 1112.77
Dec 1111.48
Dec 1116.99
Nov 1118.14
Nov 1118.37
Nov 1121.12
Nov 1122.5
Oct 1112.86
Oct 1114.24
Oct 1112.63
Oct 1111.02
Sep 1112.4
Sep 1110.22
Sep 119.82
Sep 1112.38
Sep 1117.68
Aug 1118.86
Aug 1120.44
Aug 1121.61
Aug 1120.83
Jul 1121.61
Jul 1120.83
Jul 1122.4
Jul 1125.94
Jul 1124.37
Mar 1120.89
Mar 1122.12
Mar 1118.42
Mar 1125.81
Feb 1127.65
Feb 1128.88
Feb 1130.72
Feb 1131.22
Jan 1130.11
Jan 1130.72
Jan 1130.72
Jan 1130.72
Dec 1029.5
Dec 1018.76
Dec 1019.28
Dec 1023.26
Dec 1018.68
Nov 1016.29
Nov 1016.51
Nov 1016.51
Nov 1015.01
Oct 1016.43
Oct 1016.13
Oct 1014.03
Oct 1016.13
Oct 1014.41
Sep 1010
Sep 1011.15
Sep 1012.63
Sep 1011.58
Aug 1012.58
Aug 1011.31
Aug 1010.26
Aug 109.73
Jul 108.94
Jul 1010
Jul 1010.52
Jul 1010
Jul 1011.05
Mar 1032.4
Mar 1048.17
Mar 1036.65
Mar 1044.35
Feb 1029.48
Feb 1065.87
Feb 1071.7
Feb 10143.41
Jan 1081.79
Jan 1079.67
Jan 1079.67
Jan 1092.95
Dec 0974.36
Dec 09132.5
Dec 09152.98
Dec 09159.8
Dec 09195.13
Nov 09148.56
Nov 09126.88
Nov 09112.42
Nov 09168.63
Oct 09161.41
EV/EBITDA
02468med 2.37Feb 10Jul 10Oct 10Jul 11Oct 11Dec 11Mar 12
NXTH EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 126.36
Mar 126.37
Mar 126.41
Mar 126.37
Feb 126.4
Feb 126.4
Feb 126.46
Feb 126.4
Jan 126.27
Jan 126.41
Jan 126.43
Jan 126.38
Dec 116.13
Dec 112.26
Dec 112.34
Dec 112.31
Dec 112.44
Nov 112.47
Nov 112.48
Nov 112.55
Nov 112.58
Oct 112.34
Oct 112.38
Oct 112.34
Oct 112.3
Sep 112.33
Sep 112.3
Sep 112.28
Sep 112.36
Sep 112.51
Aug 112.54
Aug 112.58
Aug 112.62
Aug 112.59
Jul 112.62
Jul 112.59
Jul 112.64
Jul 112.74
Jul 112.69
Dec 101.26
Dec 101.29
Dec 101.55
Dec 101.25
Nov 101.1
Nov 101.11
Nov 101.11
Nov 101.01
Oct 101.11
Oct 101.09
Oct 100.95
Oct 101.09
Oct 100.98
Sep 100.62
Sep 100.71
Sep 100.83
Sep 100.74
Aug 100.82
Aug 100.72
Aug 100.64
Aug 100.6
Jul 100.54
Jul 100.62
Jul 100.66
Jul 100.62
Jul 100.7
Mar 101.89
Mar 102.71
Mar 102.11
Mar 102.51
Feb 101.73
Feb 103.64
Feb 103.94
Feb 107.69
Jan 104.47
Jan 104.36
Jan 104.36
Jan 105.05
Dec 094.08
NXT Nutritionals Holdings, Inc.
NXTH
Stockpicker

Video analysis: NXTH

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.